Skip to main content

Clocortolone Pivalate

Generic: Clocortolone Pivalate

Verified·Apr 23, 2026
Manufacturer
EPI Health
NDC
51672-4166
ICD-10 indication
L30.9

Affordability Check

How much will you actually pay for Clocortolone Pivalate?

In 30 seconds, see every legitimate way to afford Clocortolone Pivalate — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Clocortolone Pivalate

What is this medication?

Clocortolone pivalate is a topical corticosteroid medication used to treat various inflammatory skin conditions. It is primarily prescribed to relieve the redness, swelling, and itching associated with disorders such as eczema, psoriasis, and different types of dermatitis. As a medium-potency steroid, it is designed for application directly to the affected area of the skin to provide localized relief from irritation and allergic reactions.

This medication works by suppressing the immune response and reducing the release of natural chemicals in the body that cause inflammation. By inhibiting these inflammatory mediators, clocortolone pivalate helps to soothe the skin and decrease the discomfort caused by rashes or scaly patches. It is intended for short-term use under medical supervision to ensure that the symptoms are managed effectively while minimizing the risk of potential side effects associated with steroid treatments.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Not Publicly Available
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Clocortolone Pivalate. Official source: DailyMed (NLM) · Label effective Dec 21, 2021

Indications and usage
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and administration
DOSAGE AND ADMINISTRATION Apply clocortolone pivalate cream USP, 0.1% sparingly to the affected areas three times a day and rub in gently. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate anti-microbial therapy instituted.
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria
Use in pregnancy
Pregnancy Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Clocortolone Pivalate appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

4%

225 of 5,509 plans

Most common tier

Tier 4

On 100% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 4 (non-preferred brand)5
100%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 5 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.